Home › Research › TREM2 and immune genetics
Genetics of Alzheimer's disease: an East Asian perspective
Miyashita A, Kikuchi M, Hara N, Ikeuchi T.. Journal of human genetics, 2022-06-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer's disease (AD) is an age-related multifactorial neurodegenerative disorder. Advances in genome technology, including next generation sequencing have uncovered complex genetic effects in AD by analyzing both common and rare functional variants. Multiple lines of evidence suggest that the pathogenesis of AD is influenced by multiple genetic components rather than single genetic factor.
What this study adds
Evidence grade: Low
This is a narrative review of 26 participants. This review notes that Alzheimer's genetics involves multiple genetic components rather than a single factor, and that non-European populations are underrepresented in prior studies. It does not report a treatment or cure, but points to the need for more diverse genetic research.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Miyashita, A., Kikuchi, M., Hara, N., & Ikeuchi, T. (2023). Genetics of Alzheimer's disease: an East Asian perspective. Journal of human genetics. https://doi.org/10.1038/s10038-022-01050-z
Vancouver
Miyashita A, Kikuchi M, Hara N, Ikeuchi T. Genetics of Alzheimer's disease: an East Asian perspective. Journal of human genetics. 2023. doi:10.1038/s10038-022-01050-z. PMID: 35641666.
BibTeX
@article{miyashita2023-35641666,
author = {Miyashita, A. and Kikuchi, M. and Hara, N. and Ikeuchi, T.},
title = {{Genetics of Alzheimer's disease: an East Asian perspective}},
journal = {Journal of human genetics},
year = {2023},
doi = {10.1038/s10038-022-01050-z},
pmid = {35641666},
url = {https://doi.org/10.1038/s10038-022-01050-z}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Advances in genome technology, including next generation sequencing have uncovered complex genetic effects in AD by analyzing both common and rare functional variants.
- Multiple lines of evidence suggest that the pathogenesis of AD is influenced by multiple genetic components rather than single genetic factor.
- Previous genetic studies on AD have predominantly included European ancestry cohorts; hence, the non-European population may be underrepresented, potentially leading to reduced diversity in AD genetic research.
- Additionally, ethnic diversity may result in dissimilar effects of genetic determinants in AD.
Why it matters
This review notes that Alzheimer's genetics involves multiple genetic components rather than a single factor, and that non-European populations are underrepresented in prior studies. It does not report a treatment or cure, but points to the need for more diverse genetic research.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants26
- Evidence strengthLow
How this study scored 50/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of human genetics) |
| Journal's citation record | 1 / 4 | Journal of Human Genetics: journal h-index 112 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 1 / 4 | 26 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 62 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 12.4 citations a year over 5 year(s) since 2023 |
| Impact for its field and year | 3 / 6 | Cited 6.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 8 other studies in this library |
| Still being cited | 3 / 4 | Cited 51 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Takeshi Ikeuchi: h-index 64 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The University of Tokyo: institution h-index 1,463 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35641666) |
| Free to read | 2 / 2 | Free to read |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1038/s10038-022-01050-z
- PubMed: 35641666
- Original source →
- Free full text: Journal of Human Genetics →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.
Later studies that cite this one
8 studies in the alzhub library list this one in their references.
Related studies in TREM2 and immune genetics from nearby years
Also in TREM2 and immune genetics
83 studies in the library are filed under TREM2 and immune genetics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The TREM2 and immune genetics hub.